{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:48:38Z","timestamp":1788306518058,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.abd.2021.11.007","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T19:39:46Z","timestamp":1661974786000},"page":"704-709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["A low level of health literacy is a predictor of corticophobia in atopic dermatitis"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2469-4871","authenticated-orcid":false,"given":"Tiago Fernandes","family":"Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0064-7571","authenticated-orcid":false,"given":"Katarina","family":"Kieselova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5926-7979","authenticated-orcid":false,"given":"Victoria","family":"Guiote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7506-4971","authenticated-orcid":false,"given":"Martinha","family":"Henrique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2402-4229","authenticated-orcid":false,"given":"Felicidade","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2021.11.007_bib0005","doi-asserted-by":"crossref","first-page":"606","DOI":"10.20344\/amp.11963","article-title":"Update on Atopic Dermatitis","volume":"32","author":"Torres","year":"2019","journal-title":"Acta Med Port"},{"key":"10.1016\/j.abd.2021.11.007_bib0010","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jid.2018.08.028","article-title":"Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population","volume":"139","author":"Fuxench","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2021.11.007_bib0015","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.clindermatol.2018.05.007","article-title":"Epidemiology of adult atopic dermatitis","volume":"36","author":"Sacotte","year":"2018","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.abd.2021.11.007_bib0020","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jaci.2013.08.031","article-title":"Adult eczema prevalence and associations with asthma and other health and demographic factors: A US population-based study","volume":"132","author":"Silverberg","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.abd.2021.11.007_bib0025","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jaci.2009.10.009","article-title":"Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three","volume":"124","author":"Odhiambo","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.abd.2021.11.007_bib0030","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/jdv.14891","article-title":"Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I","volume":"32","author":"Wollenberg","year":"2018","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"10.1016\/j.abd.2021.11.007_bib0035","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","article-title":"Atopic dermatitis","volume":"396","author":"Langan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.abd.2021.11.007_bib0040","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/ajd.12331","article-title":"Factors contributing to poor treatment outcomes in childhood atopic dermatitis","volume":"56","author":"Sokolova","year":"2015","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.abd.2021.11.007_bib0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/pde.13991","article-title":"Does it work and is it safe? Parents\u2019 perspectives on adherence to medication for atopic dermatitis","volume":"37","author":"Capozza","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.abd.2021.11.007_bib0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13052-017-0330-7","article-title":"Topical corticosteroid phobia in parents of pediatric patients with atopic dermatitis: a multicentre survey","volume":"43","author":"El Hachem","year":"2017","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.abd.2021.11.007_bib0055","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1111\/jdv.15913","article-title":"A systematic review of factors influencing treatment adherence in chronic inflammatory skin disease \u2013 strategies for optimizing treatment outcome","volume":"33","author":"Eicher","year":"2019","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"10.1016\/j.abd.2021.11.007_bib0060","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jamadermatol.2017.2437","article-title":"Topical Corticosteroid Phobia in Atopic Dermatitis","volume":"153","author":"Li","year":"2017","journal-title":"JAMA Dermatology"},{"key":"10.1016\/j.abd.2021.11.007_bib0065","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2458-12-80","article-title":"Health literacy and public health: A systematic review and integration of definitions and models","volume":"12","author":"S\u00f8rensen","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.abd.2021.11.007_bib0070","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1186\/1471-2458-13-948","article-title":"Measuring health literacy in populations: illuminating the design and development process of the European Health Literacy Survey Questionnaire (HLS-EU-Q)","volume":"13","author":"S\u00f8rensen","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/j.abd.2021.11.007_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076493","article-title":"TOPICOP\u00a9: A New Scale Evaluating Topical Corticosteroid Phobia among Atopic Dermatitis Outpatients and Their Parents. Szecsi PB, editor","volume":"8","author":"Moret","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.abd.2021.11.007_bib0080","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/all.13189","article-title":"Topical corticosteroid phobia in atopic dermatitis: International feasibility study of the TOPICOP score","volume":"72","author":"Stalder","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.abd.2021.11.007_bib0085","series-title":"Tese [Doutorado em Sa\u00fade P\u00fablica] \u2012 Escola Nacional de Sa\u00fade P\u00fablica, Universidade Nova de Lisboa","article-title":"Literacia em Sa\u00fade: da gest\u00e3o da informa\u00e7\u00e3o \u00e0 decis\u00e3o inteligente. Lisboa","author":"Pedro","year":"2018"},{"key":"10.1016\/j.abd.2021.11.007_bib0090","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/eurpub\/ckv043","article-title":"Health literacy in Europe: comparative results of the European health literacy survey (HLS-EU)","volume":"25","author":"S\u00f8rensen","year":"2015","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.abd.2021.11.007_bib0095","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/jdv.16739","article-title":"Risk factors for corticophobia in atopic dermatitis","volume":"34","author":"Dufresne","year":"2020","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"10.1016\/j.abd.2021.11.007_bib0100","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1365-2133.2011.10449.x","article-title":"Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency","volume":"165","author":"Aubert-Wastiaux","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2021.11.007_bib0105","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1365-2133.2000.03473.x","article-title":"Topical corticosteroid phobia in patients with atopic eczema","volume":"142","author":"Charman","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2021.11.007_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","article-title":"Adverse effects of topical glucocorticosteroids","volume":"54","author":"Hengge","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2021.11.007_bib0115","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12887-016-0607-9","article-title":"Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis","volume":"16","author":"Siegfried","year":"2016","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.abd.2021.11.007_bib0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1525-1470.2007.00342.x","article-title":"Evaluation of Adrenal Suppression of a Lipid Enhanced, Topical Emollient Cream Formulation of Hydrocortisone Butyrate 0.1% in Treating Children with Atopic Dermatitis","volume":"24","author":"Eichenfield","year":"2007","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.abd.2021.11.007_bib0125","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1468-3083.2000.00099.x","article-title":"An open study of efficacy and safety of long-term treatment with mometasone furoate fatty cream in the treatment of adult patients with atopic dermatitis","volume":"14","author":"Faergemann","year":"2000","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"10.1016\/j.abd.2021.11.007_bib0130","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1365-4362.2002.01571.x","article-title":"An open-label study of the safety and efficacy of limited application of fluticasone propionate ointment, 0.005%, in patients with atopic dermatitis of the face and intertriginous areas","volume":"41","author":"Tan","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2021.11.007_bib0135","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1468-3083.2010.03942.x","article-title":"Optimizing the treatment of atopic dermatitis in children: a review of the benefit\/risk ratio of methylprednisolone aceponate","volume":"25","author":"Blume-Peytavi","year":"2011","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"10.1016\/j.abd.2021.11.007_bib0140","doi-asserted-by":"crossref","first-page":"499","DOI":"10.5021\/ad.2015.27.5.499","article-title":"Topical Corticosteroid Phobia among Parents of Children with Atopic Eczema in Korea","volume":"27","author":"Lee","year":"2015","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.abd.2021.11.007_bib0145","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/pde.13698","article-title":"Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers","volume":"36","author":"Bos","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.abd.2021.11.007_bib0150","author":"Espanha"},{"key":"10.1016\/j.abd.2021.11.007_bib0155","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.2340\/00015555-3220","article-title":"Topical Corticosteroid Phobia Among Healthcare Professionals Using the TOPICOP Score","volume":"99","author":"Lambrechts","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.abd.2021.11.007_bib0160","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s11096-021-01241-2","article-title":"Reducing corticosteroid phobia in pharmacy staff and parents of children with atopic dermatitis","volume":"43","author":"Koster","year":"2021","journal-title":"Int J Clin Pharm"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059622001969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059622001969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:40:44Z","timestamp":1759794044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059622001969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0365059622001969"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2021.11.007","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A low level of health literacy is a predictor of corticophobia in atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2021.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}